Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator Journal Articles Refereed uri icon

Overview

Published in

  • Leukemia

Time

Date/time value

  • 2009

Identity

Digital Object Identifier (DOI)

  • 10.1038/leu.2008.302

Additional Document Info

Parent Title

  • Leukemia

Volume

  • 23

Issue

  • 2

Publisher

  • Nature Publishing Group